In another study, elevated plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA) (Zuo et al., 2021) were noted indicating derangements in the fibrinolytic pathways and reflective of the hemostatic system's reaction to a COVID-19-induced thrombophilia. The gene discussed is PLAT; the disease is COVID-19.